study of polyherbal tablets in Iron Deficiency Anemia

Comparative study on the efficacy of Pathyadi Gutika and Tila Gutika in Pandu with special reference to Iron Deficiency Anemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/08/020787

Enrollment

Registered

2019-08-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E638- Other specified nutritional deficiencies

Interventions

Intervention1: Pathyadi Gutika: 3-7years - 250 mg Once a day 7-10 years -250 mg twice a day 11-15 years- 500 mg twice a day for the period of 1 month Oral administration Control Intervention1: Tila Gu

Eligibility

Inclusion criteria

Inclusion criteria: 1.School going children of either sex and socio economic status from age group 3- 15 yrs suffering fromPandu 2.Children with mild to moderate anemia(Hb% between 7g/dl to 11g/dl)

Exclusion criteria

Exclusion criteria: 1.Congenital disorders related with haemopoetic system like sickle cell anemia, Leukemia and Thalassemia 2.Children with any infectious diseases. 3.Children with severe anemia (Hb% below 7g/dl)

Design outcomes

Primary

Measure	Time frame
positive changes in subjective parameters and pallorTimepoint: 7th,14th,21st,28th day	—

Secondary

Measure	Time frame
Changes in Hb%,RBC,MCV,MCH,MCHC,Peripheral smear blood pictureTimepoint: On 28th day	—

Countries

India

Contacts

Public ContactDr Jyothy KB

Mahatma Gandhi Ayurved College

jyothybmenon@yahoo.com7776014076

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026